Theravance Biopharma, Inc.
TBPH
$17.07
$0.010.03%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/9/2026
-
Zacks Investment Research
9/9/2026
-
MarketBeat
9/4/2026
-
Tickeron - Stocks
8/31/2026
-
The Cerbat Gem
8/31/2026
-
MarketBeat
8/31/2026
-
MarketBeat
8/28/2026
-
MarketBeat
8/25/2026
-
TipRanks
Theravance Biopharma (TBPH, $17.01) price may drop as it broke higher Bollinger Band on Aug 21, 2026
8/22/2026
-
Tickeron - Stocks
8/21/2026
-
Tickeron - Stocks
Theravance Biopharma (TBPH, $16.99) price may drop as it broke higher Bollinger Band on Aug 19, 2026
8/20/2026
-
Tickeron - Stocks
8/18/2026
-
Simply Wall St
8/16/2026
-
Simply Wall St
8/15/2026
-
GuruFocus
8/15/2026
-
Business Wire
8/15/2026
-
MarketBeat
8/15/2026
-
Tickeron - Stocks
Theravance Biopharma (TBPH, $16.97) price may drop as it broke higher Bollinger Band on Aug 14, 2026
8/15/2026
-
Tickeron - Stocks
8/12/2026
-
Simply Wall St
8/11/2026
-
Zacks Investment Research
8/11/2026
-
TipRanks
8/10/2026
-
MarketBeat
8/10/2026
-
TipRanks: TheFly
8/10/2026
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 11, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 808 6000
Address
901 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist...
more